The ability of the transcription factor CREB in the Nac to regulate mood
The ability of the transcription factor CREB in the Nac to regulate mood
批准号:
7664379
负责人:
RONALD S. DUMAN
金额:
$31.42万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2012-07-31
关键词:
AcuteAffectiveAnimal ModelAnimalsAntidepressive AgentsBehaviorBehavioralBrain regionBrain-Derived Neurotrophic FactorCREB1 geneCandidate Disease GeneCholecystokininChronicComplexConditionDNADataDynorphinsEmotionalGene TargetingGenesGlutamate ReceptorGrantHumanKnockout MiceMediatingMental DepressionMolecularMoodsNeuronsNucleus AccumbensOpioid PeptidePathway interactionsPhenotypeProtein FamilyRangeRegulationRewardsRoleRole playing therapySocial isolationStimulusStressSymptomsVentral Tegmental Areaalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acidamino 3 hydroxy 5 methylisoxazole 4 propionatechromatin immunoprecipitationchromatin remodelingemotional stimulushedonicmood regulationpromoterresponsetranscription factor
中文摘要
项目1重点研究伏隔核中转录因子CREB的调节能力。
情绪和动机状态。我们有相当多的证据表明大脑中CREB功能增强
在几种活动应激条件下出现的区域,会导致动物的敏感度降低
对情绪的刺激,无论刺激是令人厌恶的还是有益的。相反,减少CREB
缺乏情感刺激(例如,长期的社会孤立)所造成的功能障碍,会产生相反的效果。
这些发现表明,NAC中的CREB可能是情绪之间的关键分子门
刺激及其行为反应。CREB活性和CREB活性两个极端之间的可能关系
在人类抑郁的不同亚型中看到的不同范围的症状将在
动物模型。例如,初步数据显示,NAC中CREB活动的极端变化
(活跃度过高或过低)及其行为后果可以通过以下方式纠正
慢性的、非急性的抗抑郁治疗。相关研究将鉴定靶基因,通过这些基因
CREB在NAC产生这种行为表型。编码阿片肽强啡肽的基因和
AMPA谷氨酸受体亚单位GluR1是CREB的这种靶点的例子,将在
这个项目,以及通过DNA表达阵列和芯片(染色质)确定的其他目标
免疫沉淀x启动子)阵列。芯片也将被用来表征分子机制,通过
其中CREB在染色质重塑水平上调节其靶基因。此外,该项目将
探讨腹侧被盖区CREB在调节抑郁样病变中的作用
行为,以及建立其他几个CREB家族蛋白的行为表型,我们
最近发现在VTA-NAC通路中具有非常不同的功能。
CREB功能是该中心的一大主题。该赠款的所有后续项目均代表
我们中心假设的扩展,即VTA-NAC中的CREB是享乐性和情感性的关键调节因子
州政府。后续项目通过研究VTA和NAC的其他分子成分来扩展这一主题
受CREB调控的神经元(例如,项目2中的BDNF,项目4中的CCK),帮助控制CREB
活动(例如,项目3中的妇幼保健),并通过表征它们在调节CREB复杂行为中的作用
与抑郁症相关的表型及其治疗。
英文摘要
Project 1 focuses on the ability of the transcription factor CREB in the NAc (nucleus accumbens) to regulate
mood and motivational state. We have considerable evidence that increased CREB function in this brain
region, which occurs under several conditions of active stress, causes a decrease in an animal's sensitivity
to emotional stimuli, regardless of whether the stimulus is aversive or rewarding. Conversely, reduced CREB
function, caused by a lack of emotional stimulation (e.g., prolonged social isolation), has the opposite effect.
These findings suggest that CREB in the NAc may function as a key molecular gate between emotional
stimuli and their behavioral responses. A possible relationship between both extremes in CREB activity and
the different range of symptoms seen in various subtypes of human depression will be further explored in
animal models. Preliminary data, for example, show that either extreme change in CREB activity in the NAc
(either excessively high or excessively low activity), and its behavioral consequences, can be corrected by
chronic, not acute, antidepressant treatment. Related studies will characterize target genes through which
CREB produces this behavioral phenotype in the NAc. The genes encoding the opioid peptide dynorphin and
the AMPA glutamate receptor subunit GluR1 are examples of such targets of CREB that will be examined in
this Project, as will additional targets identified with DNA expression arrays and ChIP on chip (chromatin
immunoprecipitation x promoter) arrays. ChIP will also be used to characterize the molecular mechanisms by
which CREB, at the level of chromatin remodeling, regulates its target genes. In addition, the Project will
investigate the role played by CREB in the VTA (ventral tegmental area) in regulating depression-like
behavior, as well as establish the behavioral phenotype of several other CREB family proteins, which we
have shown recently subserve very different functions in the VTA-NAc pathway.
CREB function is a major theme of this Center. All of the subsequent Projects of this Grant represent
extensions of our central hypothesis that CREB in the VTA-NAc is a key regulator of hedonic and affective
state. Subsequent Projects extend this theme by examining other molecular constituents of VTA and NAc
neurons, which are regulated by CREB (e.g., BDNF in Project 2, CCK in Project 4) and help control CREB
activity (e.g., MCH in Project 3), and by characterizing their role in mediating CREB's complex behavioral
phenotype related to depression and its treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synaptic mechanisms underlying the rapid antidepressant actions of scopolamine
-
批准号:8934161
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2014
-
负责人:RONALD S. DUMAN
-
依托单位:
Synaptic mechanisms underlying the rapid antidepressant actions of scopolamine
-
批准号:8810419
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2014
-
负责人:RONALD S. DUMAN
-
依托单位:
Role of mTOR and Synaptogenesis in the Actions of Rapid-Acting Antidepressants
-
批准号:8738247
-
项目类别:
-
资助金额:$8.23万
-
财政年份:2013
-
负责人:RONALD S. DUMAN
-
依托单位:
Role of mTOR and Synaptogenesis in the Actions of Rapid-Acting Antidepressants
-
批准号:8812007
-
项目类别:
-
资助金额:$49.17万
-
财政年份:2011
-
负责人:RONALD S. DUMAN
-
依托单位:
Role of mTOR and synaptic protein synthesis in the rapid antidepressant actions o
-
批准号:8097791
-
项目类别:
-
资助金额:$49.17万
-
财政年份:2011
-
负责人:RONALD S. DUMAN
-
依托单位:
Role of mTOR and synaptic protein synthesis in the rapid antidepressant actions o
-
批准号:8230821
-
项目类别:
-
资助金额:$49.17万
-
财政年份:2011
-
负责人:RONALD S. DUMAN
-
依托单位:
Role of mTOR and Synaptogenesis in the Actions of Rapid-Acting Antidepressants
-
批准号:8635386
-
项目类别:
-
资助金额:$57.4万
-
财政年份:2011
-
负责人:RONALD S. DUMAN
-
依托单位:
Role of mTOR and Synaptogenesis in the Actions of Rapid-Acting Antidepressants
-
批准号:8434258
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2011
-
负责人:RONALD S. DUMAN
-
依托单位:
The ability of the transcription factor CREB in the Nac to regulate mood
-
批准号:8114141
-
项目类别:
-
资助金额:$32.88万
-
财政年份:2010
-
负责人:RONALD S. DUMAN
-
依托单位:
The ability of the transcription factor CREB in the Nac to regulate mood
-
批准号:7333042
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2007
-
负责人:RONALD S. DUMAN
-
依托单位:
Profiling Gene Expression in Major Depression
-
批准号:7492640
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2005
-
负责人:RONALD S. DUMAN
-
依托单位:
Profiling Gene Expression in Major Depression
-
批准号:6944556
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2005
-
负责人:RONALD S. DUMAN
-
依托单位:
Profiling Gene Expression in Major Depression
-
批准号:7283751
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2005
-
负责人:RONALD S. DUMAN
-
依托单位:
Profiling Gene Expression in Major Depression
-
批准号:7126432
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2005
-
负责人:RONALD S. DUMAN
-
依托单位:
Early environment and the neurobiology of depression
-
批准号:6752130
-
项目类别:
-
资助金额:$3.37万
-
财政年份:2003
-
负责人:RONALD S. DUMAN
-
依托单位:
Early environment and the neurobiology of depression
-
批准号:6901029
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2003
-
负责人:RONALD S. DUMAN
-
依托单位:
Early environment and the neurobiology of depression
-
批准号:6630673
-
项目类别:
-
资助金额:$3.85万
-
财政年份:2003
-
负责人:RONALD S. DUMAN
-
依托单位:
Gene Expression Profile of Antidepressants
-
批准号:6534953
-
项目类别:
-
资助金额:$14.43万
-
财政年份:2002
-
负责人:RONALD S. DUMAN
-
依托单位:
REGULATION OF ADULT NEUROGENESIS--STRESS /ANTIDEPRESSANT
-
批准号:6614515
-
项目类别:
-
资助金额:$11.07万
-
财政年份:2002
-
负责人:RONALD S. DUMAN
-
依托单位:
Gene Expression Profile of Antidepressants
-
批准号:6642759
-
项目类别:
-
资助金额:$14.44万
-
财政年份:2002
-
负责人:RONALD S. DUMAN
-
依托单位:
海外基金